These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9636510)
1. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510 [No Abstract] [Full Text] [Related]
2. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Friemann S; Feuring E; Padberg W; Ernst W Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504 [No Abstract] [Full Text] [Related]
3. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898 [TBL] [Abstract][Full Text] [Related]
4. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. Colak T; Karakayali H; Yagmurdur MC; Moray G Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321 [No Abstract] [Full Text] [Related]
5. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience. Manu M; Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shimmura H; Inui M; Harano M; Shiroyanagi Y; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1736-8. PubMed ID: 11119912 [No Abstract] [Full Text] [Related]
6. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function. Perrea DN; Moulakakis KG; Poulakou MV; Vlachos IS; Nikiteas N; Kostakis A Int Urol Nephrol; 2008; 40(2):521-7. PubMed ID: 17978855 [TBL] [Abstract][Full Text] [Related]
7. Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. McCune TR; Thacker LR II; Peters TG; Mulloy L; Rohr MS; Adams PA; Yium J; Light JA; Pruett T; Gaber AO; Selman SH; Jonsson J; Hayes JM; Wright FH; Armata T; Blanton J; Burdick JF Transplantation; 1998 Jan; 65(1):87-92. PubMed ID: 9448150 [TBL] [Abstract][Full Text] [Related]
8. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. Pohanka E; Margreiter R; Sparacino V; Sperschneider H; Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490 [TBL] [Abstract][Full Text] [Related]
9. Lipid profile in renal transplant recipients under various immunosuppressive regimens. Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821 [No Abstract] [Full Text] [Related]
10. Dislipidemia at different immunosuppressive protocols. Zezina L; Rosental R Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123 [No Abstract] [Full Text] [Related]
11. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Neal DA; Gimson AE; Gibbs P; Alexander GJ Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583 [TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia. Kohnle M; Zimmermann U; Lütkes P; Albrecht KH; Philipp T; Heemann U Transpl Int; 2000; 13 Suppl 1():S345-8. PubMed ID: 11112029 [TBL] [Abstract][Full Text] [Related]
13. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus? Gelens MA; Christiaans MH; v Hooff JP Transplant Proc; 2005 May; 37(4):1900-1. PubMed ID: 15919498 [TBL] [Abstract][Full Text] [Related]